References
- Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol 1984; 131: 1–8
- Daljeet S, Amreek S, Satish J, Raman A, Hara GS, Lovneesh G, et al. Signet ring cell adenocarcinoma of the urachus. Int J Urol 2004; 11: 785–8
- Merchant SH, Amin MB, Tamboli P, Ro J, Ordonez NG, Ayala AG, et al. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol 2001; 25: 1515–9
- Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 2004; 121: 884–92
- Gonzalez-Lois C, Rodriguez-Peralto JL, Serrano-Pardo R, Martinez-Gonzalez MA, Lopez-Rios F. Cutaneous signet ring cell carcinoma: a report of a case and review of the literature. Am J Dermatopathol 2001; 23: 325–8
- Ro JY, el-Naggar A, Ayala AG, Mody DR, Ordonez NG. Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol 1988; 12: 453–60
- Ghannoum JE, Freedman PD. Signet-ring cell (mucin-producing) adenocarcinomas of minor salivary glands. Am J Surg Pathol 2004; 28: 89–93
- Suzuki K, Morita T, Tokue A. Primary signet ring cell carcinoma of female urethra. Int J Urol 2001; 8: 509–12
- Chen KT, Workman RD, Rainwater G. Urachal signet-ring cell carcinoma. Urology 1990; 36: 339–40
- Fiter L, Gimeno F, Martin L, Gomez Tejeda L. Signet-ring cell adenocarcinoma of bladder. Urology 1993; 41: 30–3
- Grignon DJ, Ro JY, Ayala AG, Johnson DE. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 1991; 95: 13–20
- Loggie BW, Fleming RA, Hosseinian AA. Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. Urology 1997; 50: 446–8
- Antunes AA, Siqueira TM, Jr, Falcao E. Vesical metastasis of gastric adenocarcinoma. Int Braz J Urol 2004; 30: 403–5
- Mangiacapra FJ, Scheraga JL, Jones LA. Mucinous colloid adenocarcinoma of the urachus. Radiographics 2001; 21: 965–9
- Suh N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 2005; 18: 1217–22
- Reis-Filho JS, Carrilho C, Valenti C, Leitao D, Ribeiro CA, Ribeiro SG, et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?. Pathol Res Pract 2000; 196: 835–40
- Tian W, Osawa M, Horiuchi H, Tomita Y. Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci 2004; 95: 491–5